Genetic Technologies’ (ASX: GTG; NASDAQ: GENE) capital management program has been expanded with additional commitments received for a $800,000 private placement. There has also been an increase of underwriting for its Share Purchase Plan by $400,000 to $1.8 million.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.